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ABSTRACT 
FACTORS  INFLUENCING  PLATELET  APHERESIS  YIELD  AND  EFFECT  
OF  DONATION  AMONG  DONORS. 
The  development  in  transfusion  practice  with   discovery  of  advanced  cell 
separators  have  defined  platelet  therapy  in  terms  of  quality  and  productivity.   
Previous  studies  have  shown  that  transfusion  of  high  yield  platelet  products  
could  reduce  the  requirement  of  transfusion  among thrombocytopenic  patients 
The  aim  of  this  study  was  to  investigate  the  factors  that  influence  the  
platelet apheresis yield  among  apheresis  donors by  studying  the donor  variables   
and  machine  variables  . Differences  in  donors  peripheral  count  pre  and  post  
apheresis  procedure   were  also  studied.  Correlation  of  serum  ferritin  level  with  
platelet  apheresis  yield  was  also  determined  in  this  study. 
A  prospective  study  was  conducted   from  September  2015  to  August  2016  
at Hospital  Universiti  Sains  Malaysia  ( HUSM)  ,  Kubang  Kerian,  Kelantan.   
Thirty  five  male  subjects  were  recruited  for  this  study   
Full  blood  count  (  FBC  )  and  serum  ferritin  were  taken  prior  to the 
donation.  Post  donation,  another  sample  of  FBC  was  taken.  FBC  and  serum  
ferritin  was  run  by    Diagnostic  Stago  haematology  analyser  Sysmex  XE  5000  
and  Bio-Architect  respectively.  FBC  was  analysed  pre and  post donation  for  
haemoglobin level,  haematocrit  and  platelet  count. Other  donors  demographic  data  
which  included  age,  height,  weight,  frequency  of donation  and ABO  blood   group 
were  taken  from  the  donor  apheresis  registry  book.  Data  regarding  machine  
variables  (  anticoagulation  infusion  rate,  processing time  and  plasma volume 
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collected ) were  retrieved  from  the  apheresis  machine.  The  apheresis  machine  
used  in  this study  was  Trima  Accel cell  separator. 
Height,  pre donation  platelet  count  and  machine  variables   revealed   
significant  positive  correlations  with   platelet apheresis  yield. There  were  also  
significant  differences  in  donor  peripheral  counts  pre  and  post  apheresis 
procedure.  Positive  correlation  of  serum  ferritin  level  with  platelet  yield  was  
seen.  No  significant  IDA  was  detected  among  the  apheresis donors.   
In  conclusion,  some of  the  donors’  and  all   machine  related  variables 
showed  significant  relationship  with  platelet apheresis yield.  There  were  also  
significant  changes  pre  and  post  donation  peripheral counts.  Donors  with  high   
pre  platelet  count  with  adequate  optimisation  of  machine  variables  can  potentially  
produce  a  higher  platelet  apheresis  yield  collection. 
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ABSTRAK   
FAKTOR  YANG  MEMPENGARUHI  KEPEKATAN  AFERESIS  PLATELET  
DAN  KESAN  PENDERMAAN  KEPADA  PENDERMA. 
Kemajuan  dalam  bidang  transfusi  telah  dikenal  pasti  dengan  penemuan  
mesin  yang  bernama  “ Mesin  apheresis ˮ  atau  “ sel pemisah ˮ  yang  dapat 
menghasilkan  platelet  yang  effisien  dari  segi  kualiti  dan  produktiviti.  .  Kajian  
telah  membuktikan  bahawa  pemindahan  komponenen  platelet  aferesis  yang 
berkepekatan  tinggi   boleh  membantu  mengurangkan  keperluan  pemindahan  
platelet  dalam  kuantiti  yang banyak  kepada  pesakit  yang  mengalami  masalah  
kekurangan  platelet.   
Tujuan kajian ini adalah untuk mengkaji faktor-faktor yang mempengaruhi hasil 
platelet  aferesis di  kalangan  penderma  aferesis  tetap  dengan  mengkaji  
pembolehubah  penderma dan  mesin  aferesis.  Perbezaan  kiraan  penderma  periferal 
pra dan  selepas  prosedur  juga  di  kaji.  Perhubungan  di  antara  tahap  serum  ferritin 
dengan  hasil  pekatan  platelet  aferesis  juga  elah  diselidk  dalam  kajian  ini. 
Satu kajian telah dilakukan dari bulan September 2015 hingga Ogos 2016 
(selama  tempoh 11 bulan) di HUSM, Kubang Kerian, Kelantan.   Seramai  35  
penderma  apheresis di  ambil  sebagai  subjek  kajian  dimana  kesemua  penderma  
tersebut  terdiri  daripada    kaum  lelaki. 
Ujian  kiraan  sample  darah  sel  darah  penuh dan  tahap  serum  ferritin  di  
ambil  sebelum  pendermaan.  Selepas  pendermaan,  cuma  ujian  kiraan  sel  darah  
penuh  sahaja  telah di  ambil.  .  Ujian  tersebut  dikendalikan  oleh  mesin  Diagnostik  
Stago  penganalisa  hematologi   Sysmex  XE  5000  dan  mesin  Bio-architect.  Ujjian  
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kiraan  sel  darah  penuh  di analisa  untuk  mengenal  pasti  bacaan  sel  daha  
haemoglobin,  hematokrrit  and  skiraan  sel  darah  platelet  sebelum  dan  selepas  
pendermaan.  Sebahagian  pembolehubah  data  demografik  penderma  seperti,  umur,  
ketinggia,  berat,   kekerapan  menderma  dan  kumpulan  darah  ABO  penderma  di  
ambil  dari  buku  pendaftaran  apheresis  penderma.  Bagi  data  untuk  parameter  
mesin  seperti  kadar  anti-koagulasi,  masa  pemprosesan  dan  bilangan  plasma  
terkumpul  telah  di  ambil   dari  mesin  aferesis.  Jenis  mesin  aferess  yang  di  
gunakan  dalam  kajian  ini  ialah  Trima  Accel  sel  pemisah 
 Kajian  membuktikan  bahawa  ketinggian  dan  bilangan  sel  darah   platelet  
pra  penderma  serta   kesemua   pembolehubah  mesin   menunjukkan  hubungan  
secara  langsung  dengan  kepekatan  hasil  platelet.  Kajian  juga  membuktikan   
terdapat  pengurangan    ketara  dalam  bilangan  sel  darah sebelum  dan  selepas  .  
Hubungan  secara  langsung  dapat dilihat  di  antara  tahap  serum  ferritin  dengan   
kepekatan  hasil  platelet  serta  kesemua  subjek  kajian  kami  memiliki  tahap  serum  
feritin  yang  normal. 
 Kesimpulannya, sebilangan pembolehubah  penderma  serta kesemua  
bolehubah mesin hubungan yang berkait  rapat dengan hasil platelet apheresis. Terdapat 
juga perubahan ketara ujian  sel  darah  penderma  sebelum  dan  selepas  pendermaan. 
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1.0 GENERAL  INTRODUCTION 
Platelet  transfusion  has  been  one  of  the  most  important  supportive  
therapies  for thrombocytopenic  patients.  This  is   clearly  evidenced  by   persistent  
increase  in  the  number  of  platelet  transfusion  over  the  past  few decades.  
However, platelet  transfusion  have  also  evoked  dilemma   which  was  mostly  due  
to  non-judicious  usage  and  request  of  platelet  transfusion.  As far as platelet 
component  is  concerned,  platelets  were  collected  from  whole  blood  donation  
where  they  prepared  the  components  via  a  soft  spin  centrifugation  before  
separating  them  into  platelet  rich  plasma  component  (  Jefffrey  McCulogh,   
Transfusion  Medicine,  Second  Edition,   2005  )   
However,  the  advent  of  new  technologies  and  rising  in  medical  as  well  as  
surgical  indications  have  forced  the  blood transfusion  services  to  increase  the  new  
method  in  preparation  of  platelet  component  which  was  known  as  single  donor 
platelet  or  also  named  as  apheresis  platelet  (  Shukla,  et  al.,  2005  ).  The  new  
generation  of   cell  separators  have  made  possible  to  obtain  a  high  quality  
platelets  with  minimum  donor  manipulation.  Anyway,  the  transfusion  specialist  
was  very  concerned  about  the  collection  of  platelets  that  could  able  to  generate  
an  optimum  level  of  yield  in  order  to  balance  the  pre  and  post  donation  
hematological  counts   in  the  donors  (  Goodnough  et  al.,  1999  ). As  a result,  this  
cause  the  arise  of  research   to  demonstrate  the   possible  associative  factors  that  
would  determine  the  platelet  apheresis  yield  and  effect  of  donation  among  
apheresis  donors.   
Previous  study  done  by   Goodnough  et  al.,  (  1999 )    had  shown  the  
direct  relationship  of  pre  donation  platelet count  with  the  platelet  apheresis  yield.  
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Besides  that,  different  trials  showed  gender  had  a  significant  influence  on  the  
platelet  apheresis  yield.  Women  had  higher  yield  compared  to males  donor,  as  
reported  by  Kalish  et  al., ( 1987  ).  Those  are  the  variables  investigated  by  the  
previous  studies  and  was  categorized  as  donor  predicting  variables.  They  have  
found   that  those  variables  have  significance  influence  on  the  platelet apheresis 
yield. 
On  the other  hand,  additional  studies  that  was  done  have  cause  the  discovery  
of  other  variables  that  could  influence  the  platelet apheresis  yield.  Studies  was  
proven  by  researchers   that  found  a  direct  correlation  between  the machine  related  
variables  like  anticoagulation  infusion  rate,  processing  time  and  plasma  volume  
collected  with  platelet  apheresis  yield  collection  (  Enein,  et  al  2006  ). 
  A  higher  platelet apheresis yield  collection  could  help  to  produce  a  greater  
increment   of  platelet  count  after   transfusion  specifically  among  patients  with  
various  medical  conditions.  This  group  patients  have  the  vulnerability  to  get  
exposed  to  many  blood  and  plasma  product  of  transfusion  in  order  to  optimise 
their  blood  counts  ( Parash  A.,  et  al  2009 ).  Single  donor  platelet  transfusion  
with  good  yield  collection  could  ultimately  increase  the  platelet  count  post  
transfusion  and  also  prolonged  the duration  of  platelet  free  transfusion period.    
The  longer  the  period  of  platelet   transfusion  free   period,  the  less  likelihood  for 
the  patients  to  be  exposed to  various  complication  due  to  platelet  transfusion  
therapy  (  Despotis.,  et  al  1999  ). 
 Therefore,  a  study  was  done  in order  to  justify  these  possible factors that  
would  influence  the   yield  which  could  be  a  good  predictive  value  in  future  to  
obtain  a  product  with  good  platelet  apheresis  yield.(M. and A., 1998)  
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2.1 BACKGROUND 
The first successful  transfusion  ever  done before  was  on  a  woman  who  had  
recovered  from  severe  post  partum  haemorrhage  after  receiving  eight  ounces  of  
blood  from  Dr  James  Blundell’s  assistant  during  the  course  of  three  hours. 
(Leonard,  2006).  It  was  more  than  150  years  after  the  discovery  of human  blood  
circulatory  system  by  Sir  William  Harvey in  1628.  However  in  the  era  of  20
th
  
century,  the  discovery  of  Dr  Karl  Landsteiner  of  four  main  groups  of  blood  A,  
B,  AB,  O  has  led  blood  transfusion  evolve  into  a  new era of  saving  lives  
(Learoyd, 2006)     
The  first  record  of  blood  donation  was  performed  by  the  British  Red  
Cross  in  year  1921  and  in  return,  the  first voluntary  blood  service  had  been  
recorded.  Blood  donation  had  become  well known  long  before  time,  and  by  year  
1937,  both  America  and  Britain  had  their  first  set  up  of  blood  bank .  Currently,  
the  noble  service  of  blood  donation  and apheresis  donation  is  provided  by  
various  health  care  institutional and  blood  bank  centres (Enein et al., 2007a).  
Despite  of  having  said  that  all  donation  processes  are  non-remunerated,  the  
safety  issues  in  that  procedures  had  become  an  issues  to  be discussed  and  
ascertained.  However,  based on  previous  published articles,  many  authors  
concluded  that  whole  blood  donation   and  apheresis  donation  are  safe  (Winters, 
2006) 
These  reviews  are  partly  agreed  upon by  many  health  care  providers  as  
due  to  the  very  minimal  and   mild  form  of  complications  caused  by  transfusion.  
Rarely,  very  serious  complications  are  encountered  during  or  after  the procedures  
of  transfusion,  thus  precautions  need  to  be  taken  in order  to  provide  the  best  
care  management  for  the  recipients.  However,  despite of  having  a  safe  image  on  
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donations,  not  many  study  articles  or  feedback  reviews  had  been  done  on the  
safety  values  of the  aspect  donations  especially for  platelet apheresis  donations  
(Winters, 2006).   
In  addition,  with  increasing  use  of  single  donor  platelet,  the  need  for  
potential  platelet  apheresis  donors  also  increases.  Although  the  collection  of  
quality  single  donor  platelet  was  more  efficient  by  the  discovery  of  cell separator 
but  anyhow,  by  identifying the  possible  related  factors  that  influence  the  platelet  
yield  like  via  donor  and  machine  related  variables  could  determine  a  potential  
apheresis  donors  to  produce  a  good  platelet  yield  (Das et al., 2005).   
Thus,  it  is  important to  study  all  these  factors  and  to apply  these   related 
parameters  as  predictive  values  in  order  to  get  a  good  quality platelet  products   
(Guerrero-Rivera et al., 2003). 
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2.2     BLOOD  DONATIONS. 
Blood  donation  are  divided  into  two  categories,  these  are  whole  blood  
donation  (whole  blood  is collected  from  the  donor)  and   automated  apheresis  
donation  (only  selected  blood  component  is  collected).  The  frequently  collected  
blood  donation  is  whole  blood  donation,  although  there  is  no  absolute  indication  
for  routine  use  except  on  few  circumstances  where  whole blood  is  applicable  in  
exchange  transfusion  and  replacement  of  massive  blood  loss  where   fresh  whole  
blood  is  recommended  (Harmening, 2012). 
In  addition,  the  major  function  of  whole  blood  is  that  it  serves  as  source  
of  material  for  blood  component  preparation.  As  far  as  whole  blood  is  
concerned,  it  contains  red  blood  cells,  white  blood  cells,  platelets,  plasma  and  
few  other  components  (Hoffbrand,  Postgraduate  of  Haematology,  2008).  In  order  
to  depart  it  into  component  preparation,  a  manual  processing  and  separating 
procedures  are  essential  in  the  blood  bank. 
  A  series  of  laboratory  work  processing  is  required  to  separate  the  whole  
blood  proportion  into  several  other  components  such  as:  centrifugation,  freezing  
and thawing,  adhering  to a  standardized established  guideline  system  (Harmening,  
Modern  blood  banking,  2010 ).   
However,  with  evolutions  of  current  modern  technology  have  actually 
given  us  the  privilege  to  extract  the  whole  blood  component  into  a  plasma  
component  by  using  automated  apheresis  machine  (R.  Chaudhary  et  al,   2006  )). 
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Apheresis  defined  as  ‘separate’  which  was  derived  from  a  Greek  word  
(Rudmann, 2005).  This  term  refers  to  the process  of  removal  of  whole  blood  
from  a  donor  or  patient,  whereby  a specific  portion  of  the individual’s  blood  
were  removed  and  separated  inside  the  apheresis  machine  eventually  returning  
the  remaining portions  to  donor  or the  patient  himself  ( Figure  1.1).  Apheresis  has  
various  purposes  to  fulfil  which  include  harvesting  specific  component  for  
transfusion,  collecting  plasma  for  further  processing,  or  removing  specific  
pathologic  substances  from  a  patients  blood.  Apheresis  can  be  divided  into  three 
types like:  cytapheresis,  plasmapheresis,  and  therapeutic  apheresis.  (Prashant  A  et 
al,   2006  ) 
Cytapheresis  was  preferably  done  for  harvesting  specific  cellular  
components  such  as  platelets  (plateletpheresis)  or  granulocytes  (leukapheresis).  
Each  of  the  procedure  shall  remove  the desired  component and return  the  rest  
back  to  the  donor.  Plasmapheresis  is  a  procedure  of  separation  of  plasma  from  
the  donor  by  using   replacement  solution  like  colloid  or  albumin  and  returning  
the  rest  to  the donor.  The  purpose  of  replacement  solution  is  to  maintain  an 
equilibrium balance  of  oncotic  pressure.  (  Prashant  A  et  al,  2009 ) 
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Figure  1.0 ;  Schematic  diagram  of  apheresis  procedure  (Adapted  from  
apheresis  programme  British  Columbia,  2013  ). 
 
In  the  early  1900s,  apheresis  procedure  was  performed   laboriously  by manual  
techniques  which  resulted  in  limited  success  and  acceptance.  Automated  apheresis  
was  developed  in  year  1975  and  since  then  a  series  of evolutions  had  taken place  
in  terms  of  technical  aspect,  modification  and  established  standardization  in  order  
to  meet  the inventory  needs  of  transfusion  services  (Lazarus  et  al;  2001). 
As  far  as  apheresis  procedure  is  concerned,  the  desired  apheresis  
procedure  that  were  performed , varies  according  to  the  component  of  the  blood  
to  be  harvested and  the  equipment  to  be  used.  The  most  commonly  applied  
method  was  the  centrifugation  method  of  separation.  This method  can  be divided  
into;  (1)Intermittent  flow  centrifugation  (IFC)  and   (2)  continuous  flow  
centrifugation  (CFC)  ( Harmening,  2005). 
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Besides  that,  apheresis  via  membrane  filtration  is  occasionally  used.  The 
recommended  time  for  apheresis  procedure  can  range  from  45  to  120  minutes 
(Harmening, 2005). 
The  table 1  below  showed  the  possible  of  advantages  of  centrifugation  method  
compared  to  membrane separation  method.     (  Adapted  from  apheresis  programme  
British  Columbia,  2013  ) 
Table 1  :  Comparison  between  two  methods  of  cellular  separation. 
Centrifugation 
 
Higher plasma extraction efficiency 
Membrane Separation 
 
Lower plasma extraction efficiency 
 
Low blood flow rate (50-100mL/min) 
 
High blood flow rate (400-600mL/min) 
 
Peripheral (or central) venous access Central venous access 
 
Citrate (  anticoagulant  ) 
 
Heparin (  anticoagulant  ) 
 
Selective cell removal 
 
Selective plasma protein removal 
 
Specifically designed machines Use on existing dialysis machines 
Risk of cellular loss 
 
Risk of haemolysis 
 
 
In  this  study,  the  method  applied  was  through  centrifugation  method  of  
cellular  separation  by  using  the  apheresis  devices.  The  IFC  is  basically  
performed  in  a  number  of  cycles.  An  anticoagulant  should  be  added into  the 
tubing system  to  prevent  blood  from  clotting.  After  the  venepuncture,  the  whole  
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blood  would  flow  through  the  inlet  port,  causing  the  bowl  to  rotate  at  a  fixed  
speed, separating  the  components to  their  specific  gravities.  The  whole  blood  
would  be  separated  according  to  the  desired  components  base  on  their  mass  
value  in which  red  cells  were  packed  at  the  outer  rim  of  the  bowl,  followed  by  
white  cells,  platelets, and  plasma.  The  apheresis  machine  used  in  this  study  was  
the  Trima  Accel  cells  separator  machine.  The  separated  desired  components  are  
diverted  into  the  re-infusion  bag  and  returned  to  the  donor.  The  process  of 
reinfusion  would  complete  the  first  cycle  process. It  takes  six  to  eight  cycles  to  
collect  a  therapeutic  dose.  IFC  procedure  can  be  done with  only  one  
venepuncture  (Trudell and Harmening, 2005). 
The  most  commonly  utilized  apheresis  machines  are  the  Haemonetics  and  
Trima.  In  this study, Trima  machines  were  used  for  the  processing  of  plateet  
apheresis yield.  These  machines  are  portable,  versatile  and  capable of  efficient  
component  collection.  CFC  procedures  allow withdraw,  process  and returning  of  
blood  back  to  the  individual  simultaneouslyutilizes  the  method  of  continuous  
flow  cell  separator.  CFC  procedures  allow  withdraw,  process,  and  returning  of  
blood  back  to  the  individual  simultaneously    (Roback et al., 2008).  
Since,  the  process  of withdrawing  and  returning  of  the  blood  was  done  
continuously,  two  venepuncture  sites  were  absolutely necessary.  In  occasional 
basis,  a  dual  lumen  central  venous  catheter  was  used.  The  components  are  
separated  via  centrifugation, and  the  specific  component  required  was  diverted  
into  a  satellite  collection  bag.  The  remaining  of  the  blood  was  reinserted  back  
into  the  donor  via  second  venepuncture.  As  a  result,  the  process  of  phelobotomy,  
separation,  and  re  infusion  was  not  interrupted.  This  was  totally  in  contrast  with  
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IFC  procedures,  in  which  a one  cycle  of  complete  process  need  to  be  
accomplished  before  beginning  the  next  one.  Examples  of  machine  employing  
this  concept  are  the  Fenwal  CS-3000,  The  Amicus,  COBE  Spectra  and  Fresenius  
AS-104 (Harmening  2005)  and (Roback et al., 2008) 
The  process  of  component  collection in  apheresis  was  done   to  obtain  a  
specific  blood  component  known  as  platelet  apheresis  product.  During  this  
procedure named,   the  donor  losses  only  a  specific  cellular  component,  while the   
remaining  composition  of  blood  which  were  the  red  cells  and  plasma  component  
was   returned  back  to  the  donor.  As  for  this  reason,  apheresis  donation  can  be  
allowed  for  more  frequent  donations  compared  to  whole  blood  donations .The  red  
cell loss, should  not  exceed  more  than  25  ml  per  week,  or 24  times  in  year.  This  
was  because  donors  who  loses  large number  of  red  cells  would  cause  them  to  
have  significant  reduction  in  their  haemoglobin  level,  which  can  lead  to  anaemia  
(Rudmann, 2005).  
A s  for  the  plasma  loss,  a  maximum  of  500  ml  volume  could  be  retained  
during  the  procedure  or  the  volume  described  in  the  labelling  for  the  automated  
blood  cell  separator  device  (Roback et al., 2008)  
More stringent  regulations  was  expected  for  donors  who  participated  in  a  
serial  apheresis  program  (more  than  once  in  4  weeks)  (Harmening,  2005  ).  As    
this  group  of  regular  donors,  a  proper  assessment  and  careful  monitoring  of  
height,  weight,  pre  donation  platelet  count,  pre  donation  haemoglobin  level  and   
haematocrit  level  was  essential  in  term  of   determining  the  positive  predicting   
variables  that  could  contributed  a  good  platelet  yield  collection  ( S.  S.  Das,  R.  
K.  Chaudry  et  al,  2005).  Study  done  by  Chaudhary  D,  2005  had  demonstrated  
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that  there  was  a  direct  correlation  observed  between  the  pre  donation  platelet  
count  and  platelet  apheresis  yield.  Other  than  that,  Guerrero-  Rivera,  2003  had  
also  proven  that  there  was  an inverse  relationship  seen  between  pre  donation  
haemoglobin  level  and  platelet  apheresis  yield.  But  Ogata,  1981  observed  no  
correlation  seen  between  the  pre  donation  haemoglobin  level  with  platelet 
apheresis  yield.  This  contradicting  findings,  could  be  a  good  space  for this study  
to  be  conducted  in order  to  determine  the  correlation  between  pre  donation  
haemoglobin  level  and  platelet  apheresis  yield.    
Besides  that,  studying  the  machine  predicting  variables  could  also  be  
helpful  in  producing  a  good efficient number of  platelet  yield  collection  which  
includes,  the  processing  time,  duration  of  the  procedure,  anticoagulation  infusion,  
plasma   volume  collected.  (  Enein,  2006).  As  been  done  previously in  studies  by  
the  same  author,  he  demonstrated  a  direct   positive  correlation  between  the  
machine  related  variables  with  the  platelet  apheresis  yield  collection. 
However,  not  many  studies  have  been  done   in   Malaysia  to  determine  the  
specific  factors  that  could  influence the  quality  of  platelet apheresis yield.  Apart  
from  that,  research  papers  on  the  aspect  of  complications  due   to  platelet  
apheresis  procedure  were  still  small  in  number.  Therefore,  more  studies  related  
to  factors  influencing  the  platelet  apheresis  yield  and  effect  of  donation  among  
apheresis  donors  should  be  done  in  future  (Enein et al., 2007a) 
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2.3 PLATELET  APHERESIS  PREPARATION  AND    
      ADVANTAGES. 
Emerging  phenomena  of  increasing  demand  in  blood utilization  which  was  
not  parallel with  increasing  number  of  donor  population  pool,  leads  to  maximum  
utilization  of  blood donation  for  each  donor.   
The  platelet products  were  derived  by  two  methods  which  is  whole  blood  
derived  platelets  (platelet-rich plasma  (PRP)  or  buffy  coat  intermediate  steps ),  or 
apheresis  derived  platelets. However, choices of  producing  platelet was mainly 
dependant on  local  supply,  physician’s  preferences,  or  economic  considerations.  
Single  donor  platelet  or  also knows  as  apheresis  platelets  have  more  advantages  
to  patients  who  developed  refractoriness  to  the  random  donor  platelet  as  a  result  
of  frequent  transfusion. These  groups  of  patients  requires  a  Human  Platelet  
Antigen  (HPA)  or  Human  Leukocyte  Antigen  (HLA)  matched  platelet  products  
that would   benefit  them  by  having  less  complications  of  transfusion  and  better  
increments  in  platelet  counts  after  receiving  an  apheresis  platelet  product  (  
Vassallo  and  Murphy,  2006). 
Whole  blood  derived  platelets  was  prepared  directly  from a  whole  blood  
donations  via  a  process  of  centrifugation  whereas   apheresis  derived  platelets  
were  prepared by  connecting  a donor  to  an  apheresis  machine  set  with  double  
venepuncture  site.  In  apheresis,  the  donors  whole  blood  was  anticoagulated  as  it  
passed  through  the  instrument  in  which  the  blood  was  separated  into  red cells,  
plasma  and  leucocyte  platelet  fraction.  Then  the  desired  fraction  or  components  
were  removed,  and  the  remainder  of  the  blood  were  recombined  and  returned  
back  to  the  donor.  Several  litres  of   blood  was  processed  simultaneously  during  
the  procedure  and  therefore  a  larger  amount  of  desired  component  could  be  
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obtained  from  one unit  (  450  ml  ) of  blood  (Petz, 1989).  The   prepared   quality  
control  of  platelet  yield or  the concentration  is  equivalent  to  6  -  10  random  of  
platelet  concentrate  (Harmening,  2005).  In  regards  to  that,  the minimum  
acceptable  yield  of  platelet apheresis  product  should  contained  2.5  -  3 x 1011/L of  
platelet  yield  concentration (Roback et al., 2008).   
All  blood  components  that  were  collected  should  be  stored  at an  
appropriate  temperature.  Platelet  concentrate  or  apheresis  platelet  are  stored  at  
room temperature  within  a   range  of  20- 24⁰C  in  a  platelet  agitator  to  ensure  
their  viability and  to avoid  platelet  clumping.  A  gentle  agitation  is  essential  to  
permit adequate  gas  exchange  and  hence,  prolong  the  shelf  life  of  the  platelets  (  
Yasmin  Ayob,  2008  ).   
According  to  the  standard  AABB  guideline  and  BCSH  guideline,  the  
allowable  storage  time  of  the  platelet  is  5  days.  The  longer  the  days  of  storage  
can  augment  the  possible  of  bacterial  growth  in the  product  (Harmening, 2012).   
Besides  that,  there  were  also  progressive  decline  in  platelet  viability  
throughout  the  storage  time.  In  addition,  there  were  reflective  changes  that could  
occur in  platelet  morphology,  activation  state,  metabolic  capacity  and  
physiological  responsiveness  as  the  platelets  shelf  life  prolongs  (Fijhneer,  1989  
and  Kamath  (Kamath et al., 2001).   
The  apheresis  platelet  preparation  have  their  own  advantages  and  
disadvantages as  compared  to  other  type  of platelet  preparation  which  was   
illustrated  in  table  2.0.  This  was  supported by  study  that  showed  different 
preparation  method  exhibited  different  properties  of  platelet  at  the  beginning  of 
storage  (Rinder and Ault, 1998). 
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Table  2.0 :  Advantages  of  various  type  of  platelet  preparations 
. 
Apheresis  platelets 
          Lower  donor  exposure 
          Greater  percentage  of  repeat  donors 
          Compatible  with  cost  effective,  sensitive  bacterial  detection  methods  and  promising 
                new  pathogen  reduction  technologies. 
          Less  hospital  preparation  (pooling,  point  of  care  bacterial  esting) 
          Rapid  blood  bank  issue. 
          Decreased  transfusion  service  paperwork. 
          Reduced  wastage  (compared  with  post  storage  pools). 
          Fewer  febrile,  non  haemolytic  reactions. 
          Lower level  of  platelet  activation  by  in  vitro  assays. 
Platelet  rich  plasma,  whole  blood  derived  platelets. 
           Cost  effective  than  apheresis  derived  platelets. 
           Better  dosing  flexibility. 
           Less  single  donor  plasma  exposure. 
           Greater  availability  during holidays  and  bad  weather. 
           Greater  use  of  gift  of  whole  blood  donors  without and  additionall risk  on  apheresis 
                  associated  risk. 
Buffy  coat,  whole  blood  derived  platelets 
           Provide  all the  benefits  of  platelet  rich  plasma  derived  platelets,  including pre  storage   
                    pooling.                                                Adapted  from  (Vassallo  and  Murphy,  2006) 
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The core  advantage  of  apheresis  platelet  is  to  minimise  the  number  of  
donor  exposure  and  hence  can  reduced  the  risk  of  transmission  in  viral  infection.  
In  addition,  febrile  non  haemolytic  transfusion  reaction  had  been  reported to be  
less  common  in  apheresis  platelet.  These  could  be  due  to  the  less  leucocyte  
contamination  and  as  well  as   less  non-specific  proteins  present  in  the  apheresis  
product  (Chambers et al., 1990).   Platelet  alloimmunisation  had  also  been  reported  
to  be  less severe  among  patients  who  received  apheresis  platelet  transfusion  
(Bajpai et al., 2005) 
Besides  the  benefit  to  patients  or  the  recipients,  apheresis  platelet  donation  
can  also  benefit  the  donors.  The  apheresis  donors  could  be  able  to  donate  
several  time  like  24  times  per  year  (  Rudman,  1995  )   
  Apart  from  that,  apheresis  platelets  have  additional  advantages  which  
includes  less  hospital  preparation  (pooling,  point  of  care  bacterial  testing )   and  
more  rapid  blood  bank  issue. However,  the drawback  of  apheresis  platelet   
procedure  was  the  technique  of  preparation  and  handling  the  set  of  the  device  
which had  remain  expensive  (Chambers and Herman, 1999).   
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2.3    COMPLICATIONS  OF  PLATELET  APHERESIS   
         PROCEDURES. 
Apheresis  technology  has  been  said  to  be  safe  and  efficient  procedure,  
however  no  procedures  are 100%  safe.  They  still carry  some  additional  risk  to  
the  donors.  Apheresis  technique  shares  the  same  risk  in  term  of  reactions  and  
injuries  found  in  whole  blood  donations. In  addition,  they  could have  a  unique  
complications  that  may  have  resulted  from   frequency  of  donations  and  methods  
of  collection. (Winters, 2006).  Essentially,  the  overall reactions  that  occur  
pertaining  to  the  apheresis  procedure  were  less  than the  reactions  seen  in  whole  
blood  donation.  However,  the  risk  of  severe  reaction,  requiring  hospitalization  
were  also  greater  (Despotis et al., 1999). 
Table  3.0  illustrates  the  possible  reaction  rates  among  apheresis donors.  
Few  studies  had  shown  the  most  frequent  immediate  adverse  effects  associated  
with  apheresis  donation  were  the  venepuncture  related  complications  like  
(haematoma,  pain  )  (McLeod et al., 1998). 
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Table  3.0 :  Reactions  rate  among  apheresis  donors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Reaction in apheresis  donations     (%) 
Haematoma  
or  pain 
   1.15   
Citrate  
toxicity 
   0.4   
Mild  
vasovagal 
   0.05   
Vasovagal  
with  
syncope 
   0.08   
       
Adapted  from  (Mc  
Leod  et  al.,  1998). 
 
 
 
20 
 
  The  primary  anticoagulant  used  in  the  collection  of  platelet  or  platelet  
apheresis  is  citrate.  Citrate  had  the  ability  to  chelate  calcium  ions  which  can  
result  in  hypocalcaemia.  In  the  apheresis  instrument,  the  plasma  citrate  
concentration  should  reach  to  15 – 24  mmol/L,  to  lower  the  calcium  level  which  
is  essential  for  clotting  mechanism  to  take  place.  This  requires  the  infusion  of  
anticoagulant  called  as Acid-  Citrate  Dextrose  Adenine)  solution.  However,  in-
vivo   formation  of  citrate  from  the  red  cells  metabolism  and  other  tissue  
metabolism  can  also  occur  but  various  compensatory  mechanisms  that  are  
generated  by  the  body  can  balance  these  homeostasis  changes.  Parathyroid  
hormone  can  increase  in  response  to  hypocalcaemia  due  to  citrate  chelation  
effect  and  subsequently  causing  mobilization  of  ionized  calcium  bound  to  serum  
albumin)  as well  as  diluting  the  existing  citrate  present  in  the  blood  by  total  
extracellular  fluid,  not  just  the  intravascular  space.  Besides  that,  other  organs like  
liver  and kidneys  will  also  rapidly  metabolize  citrate,  and  release  the  bound  
calcium  (Strauss, 1994). 
  Despite  of  harbouring  an  efficient  compensatory  mechanism, citrate  
infusion  that  occur  during  the  apheresis  procedure  can  ultimately  decrease  the  
ionized  calcium  levels  to  a point  where  symptoms  can  develop  in  donor.  Donors  
may  manifest  signs  and  symptoms  of  hypocalcaemia  like:  tingling  and  numbness 
sensation  or  paraesthesia  around  perioral or  acral,  shivering,  light  headedness,  
twitching  and  tremors.  Apart  from  that,  some  donors  may  also  experience  nausea  
and   vomiting.  A  further  drop  in  ionized  calcium  level  may  provoke  further  
clinical  manifestations  like  carpopedal  spasm,,  tetany,  and  seizure  (Strauss, 1996).  
The  ultimate  treatment  is  by  slowing  the  reinfusion  rate  in  order  to  allow  for  
dilution  and  metabolism  of  the  citrate.  Besides  that, slowing  the  reinfusion  rate  
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can  also  reduce  the  proportion  of  citrate  to  donor  ratio  and  eventually decreased  
the  amount  of  citrate  infused.  Administration  of  oral  calcium  simultaneously  to  
the  donor  who  did  manifest  sign  and  symptom  of  hypocalcaemia is  the  mainstay  
of  immediate  treatment  (Harmening, 2012).  In  addition,  effect  of  citrate  can  also  
include  reducing  the  level  of magnesium,  increasing  in  blood  pH  and  a  fall  in  
serum  potassium  levels  (Bolan et al., 2001). 
  Apart  from  that,  hypotension  can  also  develop  during  apheresis  collection   
and  it  is  mostly  multifactorial  due  to  intravascular  depletion,  vasovagal  reactions,  
citrate reactions,  severe  allergic  reactions,  and  air  embolism.  Hypovolemic  and  
vasovagal  reactions  are  treated  similarly.  In  case  of  hypotensive  episodes  were  to  
occur,  the  procedure  should  be  stopped  temporarily  and  a  fluid  bolus  should  be  
infused  and  if  the  insult  is  due  to  hypovolemia,  the  blood  pressure  should  
increase  and  the  pulse  rate  should  decrease  in  response  to  this  intervention  
(Bolan., et  al  2001). 
  As  far  as  allergic  reactions  is  concerned,  donors  who  are  undergoing  
collections  like  platelets,  plasma  and  granulocytes,  may  also experience such  
similar  reactions.  Besides that,  reactions  to  ethylene  oxide  that  is  used  to  sterilize  
the  disposable  sets  have  been  described  among  platelet  and  plasma  donors.  It  is  
commonly  seen  among  regular  donors  (  Susan F.,  et  al  1986  ).  Any  donors  who  
experiences  such  reactions,  should  alarm  the  managing  team  to  abort  the  
procedures  that  is  being  carried  out  and  the  subsequent  mode  of  treatment  to  be  
administered  is  dependent  on  the  severity of  the manifestations. For  simple allergic  
reactions  like:  pruritus,  rashes,  or  chills  and  rigor,  a  simple  oral  antihistamines  
would  alleviate  the  symptoms  (Winters, 2006).   
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  However,  for  more  vigorous  manifestations,  like:  intense  itchiness  
accompanied  by  shortness  of  breath,  choking  sensation,  bronchospasm  with  
hypotension,   which  is  named  as  anaphylactic  reaction  then,  probably  a  more   
prompt  treatment  is  indicated  like:  adrenalin  infusion or  aminophylline  and  IV  
line  access maintained  patent  with  saline  infusion  ( Kaplan  et  al.,  2012  ). 
  In  addition,  a  significant  fall  or  drop  in  platelet counts  after  an  apheresis  
donation  is  a  documented  complications in  many  previous  studies  (Akay et al., 
2007)  and  (Kalish et al., 1987).  According  to  some  studies,  it  takes  4  days  for a  
platelet  count  to  return  back  to  a  normal  state  for  a  male  donor  while  as  for  
female  donor,  the  established  thrombopoietin  levels  is  slightly  lower  on  day  4  
post  donation  compared  to  males,  hence  there  will be  a  slight  delay  in  returning  
of  the  platelet  count  back  to  the  baseline  level  (Dettke  et  al.,  1998). 
  Apart  from  the  transient  decreases  in  platelet  count  after  a  single  and  a  
serial  short  term  platelet apheresis  collection,  there  were  previous  studies  to  
demonstrate  the  possibility  of  significant  and  sustained  decreased  in  platelet  count  
in  a  long  term  regular  platelet apheresis  donors  (Lazarus et al., 2001). 
   Early  platelet  apheresis  instrument  utilization  can  also  cause  a  
significant   loss  of  donor lymphocytes (5  to  10 x 10
9
/procedure), hence  this  may  
evoke  the  possible  concern  of  immunosuppression  on  donors  post  procedure. As  a  
result,   apheresis  donation  had  been  limited  to  maximum  of  24  per  year,  in  view  
of  a  potential  warning  for  the  platelet apheresis  donors  to  develop  lymphocyte  
depletion and  hence,  implicating  a  possible  of  deferral  need  to  be  carried  out  for  
apheresis  donors  who  have  lymphocyte  counts  below  1.2  x  10
9
/L  (Strauss, 1994).  
However  a  newer  generation  apheresis  instruments  showed  no  significant  
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differences  in  lymphocyte  counts  and  lymphocyte  subsets  when  compared  to  non-
donors  and  whole  blood  donors  (Lewis  et  al.,  1997). 
  In  addition,  there  is  also  some  evidence  to  suggest  that  apheresis  donation  
may  produce  adverse  long  term  effects  such  as  bone  demineralization  and  
cataract  formation  (Winters,  2006). 
  There  have  also  been  isolated  case  reports  to  suggest  possible  of  long  
term  effects  of  apheresis  donations  that  could  alter  the  haemostatic  function  
among   donors  (Beyan et al., 2005) 
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2.4   FACTORS  INFLUENCING  PLATELET  APHERESIS  AND  EFFECTS      
         OF  DONATION AMONG  DONORS. 
    Overview  on  Factors  Influencing  platelet  apheresis  yield 
Platelet apheresis procedure  has  emerged  as  a  one  of  the  important  
procedures  in  determining  the  outcome  of  a  platelet  product  quality.  Based  on   
previous  studies,  this  method  of  platelet  collection  was  able  to  produce  a  better  
platelet  yield  in  terms  of  volume  as  well  as  concentration (Goodnough et al., 
1998).  Studies   illustrated  the  possible  variations  involved  in  contributions  to  the  
outcome  of  the  platelet  apheresis  yield  collection.  They  have  encountered  the  
possible    donor  related  factors  and  machine  related  parameters  could  influence   
the  outcome  of  the  platelet  yield  collection  (Das et al., 2005).  There  were  many  
factors  involved  like  the  donor  related  factors  which  comprises  of  donor’ s  age,  
gender,  height,  weight,  pre donation  haemoglobin  level  and pre  donation  platelet 
count  and  blood  group  system.  Previous  studies  demonstrated  that  the  pre-
donation  platelet  count  had  significant  influence  towards  the  platelet  yield.  
Apheresis  donors  with  pre-donation  platelet  count  of  >  250  x 109 /L  have  been  
determined  to  provide  a  desired  haemostatic  platelet  dose  for  the  recipient.  
Therefore,  platelet  yield  for  the  apheresis product  was  predominantly  dependant  
on  the  donor  pre-platelet count  (Ogata et al., 1981)  and  (Goodnough et al., 1999). 
Other  studies  had  also  showed  a  positive  correlation  between  the body  
mass  index  (  BMI  )  and  donors  age  with  the  platelet  yield  collection  (Arun et 
al., 2013).  They  suggested  that  increasing  of  body  mass  index  and  donors  age  
would  give  a  higher  platelet  yield  collection. There  was  another  study   that  
demonstrated  no  significant  correlation  between  weight  and   platelet  yield  
